- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Therapeutic Trastuzumab Deruxtecan ADC from the original Enhertu® commercial drug.
Showing the single result
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
|---|---|---|---|---|---|---|---|---|---|---|
HER2 |
Antibody-drug conjugate (ADC) |
Enhertu® |
20 mg/mL |
– |
2 mg |
-80 °C |
05/2024 |
528,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin
